Day: November 14, 2024

Reports 57% increase in international dental sales for the third quarter of 2024 Advances commercial rollout of CompuFlo® Epidural System across additional pain management clinics following Medicare price assignment in multiple U.S. states ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today reported financial results for the third quarter ended September 30, 2024. Arjan Haverhals, CEO of Milestone Scientific, commented, “We are pleased to report a 22% year-over-year increase in total revenue, reaching $2.5 million for the third quarter of 2024. This growth was primarily driven by robust performance in our dental segment, where international dental sales rose by an impressive 57%,...

MONTREAL, Nov. 14, 2024 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved JORNAY PM™, an extended-release formulation of methylphenidate, a stimulant medication for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in children. JORNAY PM™ is the first and only evening-dosed methylphenidate product commercially available in Canada to treat ADHD in patients from 6 to 12 years of age. JORNAY PM™ consists of microbeads with a delayed-release layer and an extended-release layer. The first layer delays the release of the active ingredient until morning while the extended-release layer controls the release of the active ingredient starting in the morning and continuing...

Rutherford, NJ., Nov. 14, 2024 (GLOBE NEWSWIRE) — Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the closing of a “best efforts” public offering of 2,437,340 shares of common stock and 4,756,900 pre-funded warrants, with each share of common stock and each pre-funded warrant accompanied by (i) a series A common warrant to purchase one (1) share of common stock at an exercise price of $1.81 per share and (ii) a series B common warrant to purchase one (1) share of common stock at an exercise price of $1.81 per share. The combined offering price of each share of common stock together with the accompanying series A and series B common warrants is $1.39, and the combined offering price of each pre-funded...

Austin, TX, Nov. 14, 2024 (GLOBE NEWSWIRE) — Digital Brands Group, Inc. (“DBG”) (NASDAQ: DBGI), a curated collection of luxury lifestyle, digital-first brands, today reported financial results for its third quarter ended September 30, 2024. “Our third quarter was the last quarter we significantly focused on paying down debt and liabilities given the soft macro economy and the overhang of the election. Starting in October this year, we transitioned from cleaning up the balance sheet to focusing on increasing top line growth. As we stated in our press release yesterday, we partnered with VAYNERCOMMERCE to drive digital revenue, which we announced is already working”. “This was the first step in a multi-step growth strategy, coupled with the launch of AVO. New initiatives include investing in other digital channels and platforms,...

Reports Positive Adjusted EBITDA and Expanded Gross Margins TORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX: EGLX), a leading gaming media and entertainment company, today announced financial results for the three months ended September 30, 2024 (“Q3 2024”). “This quarter marks a transformative milestone for the Company, achieving our first profitable quarter on an Adjusted EBITDA basis,” said Adrian Montgomery, Interim CEO of Enthusiast Gaming. “This accomplishment is a direct result of the strategic refocusing efforts we began in Q1 and our relentless pursuit of operational efficiencies—all achieved without compromising the growth of our communities or the quality of our content. By optimizing our operations, streamlining costs, and prioritizing high-margin...

Quarter Marks Strong Balance Sheet and Expanded Customer Engagements TORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™, Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and artificial intelligence markets, today reported its unaudited condensed consolidated financial results as at and for the three months ended November 30, 2024. The Company’s financial results as well as the Management’s Discussion and Analysis have been filed on SEDAR. All financial figures are in United States dollars (“USD”) unless otherwise indicated. Management Comments “We are very proud of the progress POET has made this quarter, particularly with strategic partnerships...

COVID: Phase 1 pharmacokinetic profile supports the potential for ratutrelvir to be dosed as a once-a-day, single drug, 10-day treatment course, without ritonavir, and with a lower likelihood of clinical rebound and good overall tolerability Flu: Phase 1 pharmacokinetic profile supports the potential for tivoxavir marboxil to be a one-time treatment for flu, including pandemic and avian flu, with good overall tolerabilityNEWTOWN, Pa., Nov. 14, 2024 (GLOBE NEWSWIRE) — Traws Pharma, Inc. (“Traws” or “Traws Pharma”), a clinical stage biopharmaceutical company developing oral small molecules for respiratory viral diseases, today outlined recent business updates and reported unaudited financial results for the third quarter ended September 30, 2024. “Traws is making excellent progress with its clinical pipeline. Phase 1 data for...

The company also donated $10,000 to City HarvestSysco Metro New York at City HarvestSysco Metro New York Donates $10,000 to City HarvestNEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) — Today, Sysco Corporation (NYSE:SYY), the world’s largest food distributor, presented a check for $10,000 to City Harvest, New York’s first and largest food rescue organization, to support the community where Sysco operates. Sysco’s donation is part of the company’s signature Nourishing Neighbors® program where a portion of the proceeds from each Sysco branded case sold in local communities is donated back to charitable organizations in those communities. This is an important time of year for food banks and pantries as they gear up to feed those in need this holiday season. Sysco Metro New York also delivered 2,500 turkeys to City Harvest to be...

Royalty Pharma inaugural Prize for Impact in Healthcare awarded to Michael Milken, the founder of the Milken Institute, Faster Cures & the Prostate Cancer Foundation The Prize includes a charitable donation to further fund medical researchNEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced the inaugural Royalty Pharma Prize for Impact in Healthcare, which honors individuals or organizations who positively impact healthcare, was awarded to Micheal Milken. The prize includes a $250,000 charitable donation to support medical research or educational initiatives that further the recipient’s work. “I am delighted to award the inaugural Royalty Pharma Prize for Impact in Healthcare to Michael Milken,” said Pablo Legorreta, founder and Chief Executive Officer of Royalty Pharma. “Mike has...

Conference Call Scheduled for today, November 14, 2024, at 5:00pm ET. GARDNER, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) — Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced operating results on an unaudited basis for its first quarter fiscal year 2025 for the period ended September 30, 2024. Q1 2025 Financial Highlights (3 Months Ended September 30, 2024):Revenue was $4.2 million compared to $4.3 million in the same quarter of the previous fiscal year and in line with the expectations provided in September 2024. Engineering revenue was $1.9 million compared to $1.9 million in the same quarter of the previous fiscal year. Production revenue was $2.3 million compared to $2.4 million in the same quarter of...